InsiderClue
Stocks · Health care · Orthopedic, Prosthetic & Surgical Appliances & Supplies

Edwards Lifesciences

EW Clue Score50
United States Fiscal year ends December CIK 0001099800 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

33
Insider
Date
Role
Action
Shares
Price
Amount
Daniel J. Lippis
8 Oct 2026
Cvp, Tavr
Sold after exercise
619
$85.65
$53.02K
Daniel J. Lippis
11 Sep 2026
Cvp, Tavr
Sold after exercise
619
$87.51
$54.17K
Daveen Chopra
26 Aug 2026
CVP, TMTT, Surgical & IHFM
Sold after exercise
30,646
$90.99
$2.79M
Daveen Chopra
26 Aug 2026
CVP, TMTT, Surgical & IHFM
Sold after exercise
1,154
$91.76
$105.89K
Daniel J. Lippis
11 Aug 2026
Cvp, Tavr
Sold after exercise
619
$92.03
$56.97K
Wayne Markowitz
28 Jul 2026
Cvp, Japac
Sold after exercise
9,628
$85.06
$818.96K
Daniel J. Lippis
10 Jul 2026
Cvp, Tavr
Sold after exercise
619
$91.70
$56.76K
Daniel J. Lippis
30 Jun 2026
Cvp, Tavr
Sold after exercise
619
$91.40
$56.58K
Daniel J. Lippis
18 May 2026
Cvp, Tavr
Sold after exercise
620
$81.14
$50.31K
Daniel J. Lippis
4 May 2026
Cvp, Tavr
Sold after exercise
1,019
$83.98
$85.58K
Daniel J. Lippis
1 May 2026
Cvp, Tavr
Sold after exercise
1,000
$82.99
$82.99K
Daniel J. Lippis
1 May 2026
Cvp, Tavr
Sold after exercise
19
$83.99
$1.60K
Scott B. Ullem
9 Apr 2026
CVP, Chief Financial Officer
Sold after exercise
8,324
$79.79
$664.14K
Scott B. Ullem
9 Apr 2026
CVP, Chief Financial Officer
Sold after exercise
4,676
$80.50
$376.40K
Daniel J. Lippis
6 Apr 2026
Cvp, Tavr
Sold after exercise
1,019
$80.98
$82.52K
Donald E Bobo Jr
2 Apr 2026
CVP,Strategy/Corp Development
Sold after exercise
18,004
$80.05
$1.44M
Donald E Bobo Jr
2 Apr 2026
CVP,Strategy/Corp Development
Sold after exercise
4,676
$80.59
$376.85K
Daniel J. Lippis
11 Mar 2026
Cvp, Tavr
Sold after exercise
1,019
$85.38
$87.00K
Scott B. Ullem
11 Mar 2026
CVP, Chief Financial Officer
Sold after exercise
7,901
$85.21
$673.23K
Scott B. Ullem
11 Mar 2026
CVP, Chief Financial Officer
Sold after exercise
5,099
$84.46
$430.67K
Donald E Bobo Jr
2 Mar 2026
CVP,Strategy/Corp Development
Sold after exercise
11,340
$85.93
$974.43K
Bernard J Zovighian
12 Feb 2026
CEO
Sold after exercise
19,898
$76.61
$1.52M
Bernard J Zovighian
12 Feb 2026
CEO
Sold after exercise
2,532
$77.13
$195.29K
Daniel J. Lippis
9 Jan 2026
Cvp, Tavr
Sold after exercise
1,019
$85.70
$87.33K
Donald E Bobo Jr
6 Jan 2026
CVP,Strategy/Corp Development
Sold after exercise
8,708
$85.98
$748.71K
Donald E Bobo Jr
6 Jan 2026
CVP,Strategy/Corp Development
Sold after exercise
2,632
$84.62
$222.72K
Daniel J. Lippis
12 Dec 2025
Cvp, Japac
Sold after exercise
1,019
$84.03
$85.63K
Donald E Bobo Jr
10 Dec 2025
CVP,Strategy/Corp Development
Sold after exercise
11,340
$83.83
$950.58K
Scott B. Ullem
9 Dec 2025
CVP, Chief Financial Officer
Sold after exercise
7,700
$84.47
$650.41K
Bernard J Zovighian
8 Dec 2025
CEO
Sold after exercise
21,487
$85.21
$1.83M
Daniel J. Lippis
10 Nov 2025
Cvp, Japac
Sold after exercise
1,020
$82.55
$84.20K
Scott B. Ullem
10 Nov 2025
CVP, Chief Financial Officer
Sold after exercise
10,026
$83.02
$832.36K
Scott B. Ullem
10 Nov 2025
CVP, Chief Financial Officer
Sold after exercise
2,974
$83.30
$247.73K
Show all 55 transactions →

What was left out

Form 4 filings counted 75
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 33
Sales at will 17
Transactions with no price 0
Shares from compensation/vesting 727,503
History held since 3 Oct 2006